Fredun Pharmaceuticals Ltd
BSE:539730
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Fredun Pharmaceuticals Ltd
Other Operating Expenses
Fredun Pharmaceuticals Ltd
Other Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Fredun Pharmaceuticals Ltd
BSE:539730
|
Other Operating Expenses
-₹363.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Other Operating Expenses
-₹85.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Other Operating Expenses
-₹72.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-7%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Other Operating Expenses
-₹180.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-7%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Other Operating Expenses
-₹73.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Other Operating Expenses
-₹30.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
Fredun Pharmaceuticals Ltd
Glance View
Fredun Pharmaceuticals Ltd. engages in the manufacture and sale of pharmaceuticals, neutraceuticals, herbal and dietary supplements. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-03-17. The firm is primarily engaged in the business of pharmaceuticals and healthcare. The company operates through pharmaceutical formulation segment. The company offers a range of products, including antihypertensives, antidiabetic, antiretroviral drugs (ARVs) and narcotics. The company is also engaged in the manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with animal healthcare products. The firm primarily exports its products to Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America.
See Also
What is Fredun Pharmaceuticals Ltd's Other Operating Expenses?
Other Operating Expenses
-363.9m
INR
Based on the financial report for Dec 31, 2025, Fredun Pharmaceuticals Ltd's Other Operating Expenses amounts to -363.9m INR.
What is Fredun Pharmaceuticals Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-30%
Over the last year, the Other Operating Expenses growth was -29%. The average annual Other Operating Expenses growth rates for Fredun Pharmaceuticals Ltd have been -28% over the past three years , -30% over the past five years .
